ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets

Vaccines against SARS-CoV-2 are likely to be critical in the management of the ongoing pandemic. A number of candidates are in Phase III human clinical trials, including ChAdOx1 nCoV-19 (AZD1222), a replication-deficient chimpanzee adenovirus-vectored vaccine candidate. In preclinical trials, the ef...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:NPJ Vaccines
Asıl Yazarlar: Marsh, Glenn A., McAuley, Alexander J., Au, Gough G., Riddell, Sarah, Layton, Daniel, Singanallur, Nagendrakumar B., Layton, Rachel, Payne, Jean, Durr, Peter A., Bender, Hannah, Barr, Jennifer A., Bingham, John, Boyd, Victoria, Brown, Sheree, Bruce, Matthew P., Burkett, Kathie, Eastwood, Teresa, Edwards, Sarah, Gough, Tamara, Halpin, Kim, Harper, Jenni, Holmes, Clare, Horman, William S. J., van Vuren, Petrus Jansen, Lowther, Suzanne, Maynard, Kate, McAuley, Kristen D., Neave, Matthew J., Poole, Timothy, Rootes, Christina, Rowe, Brenton, Soldani, Elisha, Stevens, Vittoria, Stewart, Cameron R., Suen, Willy W., Tachedjian, Mary, Todd, Shawn, Trinidad, Lee, Walter, Duane, Watson, Naomi, Drew, Trevor W., Gilbert, Sarah C., Lambe, Teresa, Vasan, S. S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8110954/
https://ncbi.nlm.nih.gov/pubmed/33972565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-021-00315-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller